Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2016
|
OGXI |
|
Phase 2 Results |
Oncology |
None |
|
H2 2016
|
OGXI |
|
Phase 2 Results |
Oncology |
None |
|
H2 2016
|
ONCE |
|
Phase 1/2 Results |
Other |
Orphan Drug |
|
H2 2016
|
OXGN |
|
Phase 2 Results |
Oncology |
Fast Track |
|
H2 2016
|
PTLA |
|
NDA Submission |
Other |
Fast Track |
|
H2 2016
|
RARE |
|
Phase 2 Results |
Oncology |
None |
|
H2 2016
|
RARE |
|
Phase 2 Results |
Other |
None |
|
H2 2016
|
RARE |
|
Phase 2 Results |
Other |
Orphan Drug |
|
Q4 2016
|
XENE |
|
Phase 2 Results |
Other |
None |
|
H2 2016
|
IRWD |
|
Phase 1b Results |
Cardiovascular |
None |
|